SOUTH SAN FRANCISCO, CA — Explora BioLabs, the West Coast’s leading preclinical facility operator and service provider, announces the opening of its flagship pharmacology incubator in South San Francisco. This 18,000 square foot facility, located in the Genesis-SSF tower in the heart of the region’s largest biotech cluster, provides high quality workspace for clients’ pharmacology research operations, as well as husbandry equipment and supplies, cell culture rooms, conference space, and regulatory and staffing support.
“Our flexible, turn-key pharmacology accelerator model is designed to fully support clients’ preclinical pharmacology research programs, while providing convenience, quality and cost savings,” said Richard Lin, PhD, CEO and Founder, Explora BioLabs. “It has been a pleasure to work with the developers, Phase 3 Real Estate Partners, on bringing this state-of-the-art facility online to the local life sciences community.”
Explora’s opening of its Genesis-SSF facility comes on the heels of its commencement of operations of a 5,000 square foot pharmacology space within the Bayer CoLaborator in San Francisco’s Mission Bay. The CoLaborator, an incubator set up to serve the laboratory needs of emerging companies, is located next to Bayer’s West Coast Innovation Center, and within walking distance of UCSF, QB3, the Gladstone Institutes and dozens of start-up life science companies.
Explora’s Bay Area operations will be headed by Marek Piechowiak, DVM. Marek has over 25 years of veterinary experience in experimental medicine and surgery at both pharmaceutical and biotech companies. During his career, Marek has also designed, managed, and provided regulatory and strategic oversight at numerous preclinical pharmacology facilities.
With the opening of its two Bay Area sites, Explora currently operates seven OnDemand preclinical pharmacology facilities in California, and provides consulting services and OnSite operational assistance to numerous Bay Area and SoCal companies with their own pharmacology facilities. Additionally, Explora provides a full complement of contract research services, including the design and execution of preclinical studies in oncology, wound healing, metabolic diseases, pharmacokinetics, and toxicology.
For more information about Explora BioLabs, please contact CEO Richard Lin (firstname.lastname@example.org or 858-997-0102).